Acerus patents expiration
1. Natesto patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8784882 | ACERUS | Controlled release delivery system for nasal applications and method of treatment |
Feb, 2024
(2 months ago) | |
| US8877230 | ACERUS | Controlled release delivery system for nasal applications |
Feb, 2024
(2 months ago) | |
| US8574622 | ACERUS | Controlled release delivery system for nasal applications |
Feb, 2024
(2 months ago) | |
| US8784869 | ACERUS | Controlled release delivery system for nasal applications and methods of treatment |
Feb, 2024
(2 months ago) | |
| US11090312 | ACERUS | Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
Mar, 2034
(9 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | May 28, 2017 |
Drugs and Companies using TESTOSTERONE ingredient
Market Authorisation Date: 28 May, 2014
Treatment: A method of testosterone replacement therapy comprising the step of nasally administering to a patient in need of such treatment an effective amount of testosterone gel formulation.; Nasal administrat...
Dosage: GEL, METERED;NASAL
More Information on Dosage
NATESTO family patents
